Skip to content

Clinical trials

Wet Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wet Macular Degeneration Country / region: United States Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20125
20144
20151
20161
20173
20182
201910
20206
20215
20223
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting8
Recruiting6
Terminated6
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
AbbVie4
Outlook Therapeutics, Inc.4
4D Molecular Therapeutics3
Adverum Biotechnologies, Inc.3
EyeBiotech Ltd.2
Hoffmann-La Roche2
Johns Hopkins University2
MD Stem Cells2
Wills Eye2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wet Macular Degeneration49
Macular Degeneration34
Eye Diseases12
Retinal Diseases11
Choroidal Neovascularization10
Retinal Degeneration10
Geographic Atrophy7
Vision Disorders6
Retinal Vein Occlusion5
Blindness4

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.